From July 1, 2023 to September 30, 2023, the company has repurchased 71,958 shares, representing 2.32% for $0.15 million. With this, the company has completed the repurchase of 129,293 shares, representing 4.14% for $0.28 million under the buyback announced on January 31, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.81 USD | +2.26% | +5.85% | +25.69% |
04-23 | Silo Pharma, Inc. Announces Positive Results for Intranasal PTSD Treatment | CI |
04-10 | Silo Pharma Says It Exercised Option to License Alzheimer's Therapeutic From Columbia University | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+25.69% | 5.15M | |
-1.26% | 89.46B | |
+2.76% | 40.74B | |
-12.32% | 33.03B | |
+54.12% | 24.68B | |
-17.39% | 15.12B | |
-9.14% | 12.81B | |
-10.48% | 11.79B | |
-42.45% | 11.64B | |
+7.19% | 8.9B |
- Stock Market
- Equities
- SILO Stock
- News Silo Pharma, Inc.
- Tranche Update on Silo Pharma, Inc.'s Equity Buyback Plan announced on January 31, 2023.